Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 10 of 10 entries
View as:

Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01830764 Org: User:
Start: 04/30/13 End: 06/30/13 Due: 06/30/14

A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel

Phase: N/A Priority: Normal
NCT ID: NCT01936324 Org: User:
Start: 08/31/13 End: 06/30/14 Due: 06/30/15

A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01993420 Org: User:
Start: 10/31/13 End: 03/31/14 Due: 03/31/15

A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02431052 Org: User:
Start: 04/30/15 End: 04/30/16 Due: 04/30/17

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03028363 Org: User:
Start: 12/27/16 End: 11/28/17 Due: 11/28/18

A Safety and Efficacy Study of DRM02 in Subjects With Rosacea

Phase: N/A Priority: Normal
NCT ID: NCT01993446 Org: User:
Start: 10/31/13 End: 03/31/14 Due: 03/31/15

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03073486 Org: User:
Start: 02/06/17 End: 12/21/17 Due: 12/21/18

A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01993433 Org: User:
Start: 10/31/13 End: 03/31/14 Due: 03/31/15

Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne

Phase: N/A Priority: Normal
NCT ID: NCT01490736 Org: User:
Start: 12/31/11 End: 06/30/13 Due: 06/30/14

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03127956 Org: User:
Start: 03/21/17 End: 04/27/18 Due: 04/27/19